China approves clinical trials of its only nasal spray COVID-19 vaccine

China's National Medical Products Administration has approved clinical trials of its only nasal spray vaccine for COVID-19. It has been jointly developed by the University of Hong Kong, Xiamen University and Beijing Wantai Biological Pharmacy. The vaccine stimulates the natural infection pathway of respiratory viruses to activate the immune response, microbiologist Yuen Kwok-yung said.